← Back to Search

Medication Adherence for Epilepsy

N/A

Recruiting

Led By Ramon Edmundo D Bautista, MD

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up to be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention)

Awards & highlights

Study Summary

This trial is testing different ways to help people with epilepsy manage their condition better. The hope is that this will lead to patients having fewer seizures.

Eligible Conditions

Epilepsy

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ to be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~to be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and to be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in Quality of Life in Epilepsy-10 scores

Trial Design

1Treatment groups

Experimental Treatment

Group I: Epilepsy PatientsExperimental Treatment4 Interventions

The group will receive the module (a 1-2 hour course on either medication adherence, seizure documentation, memory improvement or stress management) right after a baseline assessment. A post assessment and delayed post assessment will be conducted after the module is administered.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Medication Adherence

2019

N/A

~100

Stress Management

2011

N/A

~2820

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,340 Previous Clinical Trials

715,128 Total Patients Enrolled

5 Trials studying Epilepsy

496 Patients Enrolled for Epilepsy

Dupont Fund, Jesse BallUNKNOWN

Florida Blue FoundationUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies for participants in this experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial is presently searching for applicants which were initially posted on June 6th 2018 and most recently updated on 28th of June 2022. This particular investigation demands 568 participants from 1 location."

Answered by AI

What criteria should participants meet to be eligible for this clinical research?

"This research project is currently onboarding 568 individuals with aura, ranging in age from 18 to 88. To qualify for the trial, candidates must meet certain requirements including a clinical diagnosis of epilepsy according to official standards, being their own primary caretaker, having fluency in English and competency when it comes to providing informed consent as well as completing study assessments."

Answered by AI

Does this clinical trial accept individuals who are more than 30 years old?

"This medical trial is looking for participants aged 18 to 88. Furthermore, there are 121 trials specifically targeting minors and 191 studies aimed at seniors."

Answered by AI

What is the maximum capacity of participants in this experiment?

"Affirmative. Clinicaltrials.gov discloses that recruitment for this clinical study is currently underway, with the trial's initial posting taking place on June 6th 2018 and its last update being issued on June 28th 2022. The investigation requires 568 patients to be enrolled at a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy

2018. "Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03484039.

All > Lgs Foundation